Egyptians Look to Make Quick Fortune from Bats' Nests

A wall of a chamber of the tomb of Mehu near Egypt's Saqqara necropolis in Giza. (Reuters)
A wall of a chamber of the tomb of Mehu near Egypt's Saqqara necropolis in Giza. (Reuters)
TT

Egyptians Look to Make Quick Fortune from Bats' Nests

A wall of a chamber of the tomb of Mehu near Egypt's Saqqara necropolis in Giza. (Reuters)
A wall of a chamber of the tomb of Mehu near Egypt's Saqqara necropolis in Giza. (Reuters)

In Upper Egypt, the so-called "red mercury" fever has emerged again. People obsessed with this substance have been looking for it in bats' nests, looking to make a fortune.

The red substance is estimated to be worth millions of Egyptian pounds in the markets of archaeological treasures seekers. 

Some have associated the red mercury with bats because their nests are located in the columns and ceilings of ancient Egyptian temples in Luxor and Aswan. 

Many wealthy people, especially in the Arab world, believe that red mercury can extend a person’s life and preserve youth.

Red mercury was rumored to be found in an ancient coffin found in the suburb of Sidi Gaber, Alexandria in July. 

At the time, Dr. Mostafa Waziri, secretary-general of the Supreme Council of Antiquities, refuted the rumors, saying the liquid found inside the coffin was "not the juice of immortality that belongs to mummies," or the so-called red mercury, but rather sewage water.

Sewage had seeped into the coffin through a small leak from the local sewage network.

Archaeologist Mohamed Yehia Oweida told the German news agency that red mercury is "just a myth" and it was never used in ancient Egypt.

The so-called Egyptian or Pharaonic red mercury does not exist, he stressed.

Moreover, until this date, there is no archaeological or scientific evidence that proves that ancient Egyptians used it in mummification.

He denied the rumored discovery of the ancient Egyptians’ so-called "immortality code", which has been sought by humans for centuries.

Oweida highlighted many popular fake myths related to red mercury, such as the discovery of a bottle containing red liquid at the Museum of Mummification in Luxor.

People obsessed with the liquid say the bottle contains red mercury, which can turn cheap metals into precious ones.

He explained that the bottle contained brownish-red liquid. It was found under the mummy of Amun Tefnakht, commander of Egyptian armies who lived during the 27th Dynasty.

The liquid was in fact a residue of some of the materials used in the mummification process, such as sawdust, and resin, aromatic fats and linen rolls.



Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
TT

Blood Tests Allow 30-year Estimates of Women's Cardio Risks, New Study Says

A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights
A woman jogs in a park in Saint-Sebastien-sur-Loire near Nantes, France January 19, 2024. REUTERS/Stephane Mahe/File Photo Purchase Licensing Rights

Women’s heart disease risks and their need to start taking preventive medications should be evaluated when they are in their 30s rather than well after menopause as is now the practice, said researchers who published a study on Saturday.

Presenting the findings at the European Society of Cardiology annual meeting in London, they said the study showed for the first time that simple blood tests make it possible to estimate a woman’s risk of cardiovascular disease over the next three decades.

"This is good for patients first and foremost, but it is also important information for (manufacturers of) cholesterol lowering drugs, anti-inflammatory drugs, and lipoprotein(a)lowering drugs - the implications for therapy are broad," said study leader Dr. Paul Ridker of Brigham and Women’s Hospital in Boston, Reuters reported.

Current guidelines “suggest to physicians that women should generally not be considered for preventive therapies until their 60s and 70s. These new data... clearly demonstrate that our guidelines need to change,” Ridker said. “We must move beyond discussions of 5 or 10 year risk."

The 27,939 participants in the long-term Women’s Health Initiative study had blood tests between 1992 and 1995 for low density lipoprotein cholesterol (LDL-C or “bad cholesterol”), which are already a part of routine care.

They also had tests for high-sensitivity C-reactive protein (hsCRP) - a marker of blood vessel inflammation - and lipoprotein(a), a genetically determined type of fat.

Compared to risks in women with the lowest levels of each marker, risks for major cardiovascular events like heart attacks or strokes over the next 30 years were 36% higher in women with the highest levels of LDL-C, 70% higher in women with the highest levels of hsCRP, and 33% higher in those with the highest levels of lipoprotein(a).

Women in whom all three markers were in the highest range were 2.6 times more likely to have a major cardiovascular event and 3.7 times more likely to have a stroke over the next three decades, according to a report of the study in The New England Journal of Medicine published to coincide with the presentation at the meeting.

“The three biomarkers are fully independent of each other and tell us about different biologic issues each individual woman faces,” Ridker said.

“The therapies we might use in response to an elevation in each biomarker are markedly different, and physicians can now specifically target the individual person’s biologic problem.”

While drugs that lower LDL-C and hsCRP are widely available - including statins and certain pills for high blood pressure and heart failure - drugs that reduce lipoprotein(a) levels are still in development by companies, including Novartis , Amgen , Eli Lilly and London-based Silence Therapeutics.

In some cases, lifestyle changes such as exercising and quitting smoking can be helpful.

Most of the women in the study were white Americans, but the findings would likely “have even greater impact among Black and Hispanic women for whom there is even a higher prevalence of undetected and untreated inflammation,” Ridker said.

“This is a global problem,” he added. “We need universal screening for hsCRP ... and for lipoprotein(a), just as we already have universal screening for cholesterol.”